1. Understand the scope and types of donor-derived infections
2. Calculate risk for an individual donor-recipient pair, understand that some risks are acceptable while others would not be
3. Know how to diagnose and report a donor-derived infection

Camille Nelson Kotton MD, FIDSA, FAST is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts. She was chair of The Infectious Disease Community of Practice of The American Society of Transplantation (2012-2018). From 2007-2013, she was the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her time as president include the development of international guidelines on CMV management after solid organ transplant, published in Transplantation (2010, 2013, 2018). She is the first transplant infectious disease specialist to be a councilor of The Transplantation Society (2020). Her clinical interests include cytomegalovirus, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting. She is a new member of the CDC Advisory Committee on Immunization Practices (ACIP) and is involved in national decisions regarding COVID-19 vaccines. Dr. Kotton is a past member of the Disease Transmission Advisory Committee of The United Network for Organ Sharing, and has expertise in donor derived infections.

Dr. Pouch received her MD from Temple University School of Medicine in 2007. She completed her internship and residency in internal medicine at the University of Chicago, served as a chief resident at the John H. Stroger, Jr. Hospital of Cook County, and completed fellowship training in infectious diseases at Columbia University Medical Center. Dr. Pouch’s clinical and research interests relate to infectious complications of solid organ and stem cell transplantation, with a primary research emphasis on multidrug-resistant Gram-negative infections in transplant recipients.